The Joint Corporation (JYNT) - Market Cap to Earnings

Symbol and logo of brand The Joint Corp (JYNT)

The market capitalization trend for The Joint Corp. (JYNT) demonstrates a value of 32.90. Business efficiency relies on the expansion of the partner network and the availability of experienced medical professionals coupled with moderate rental costs. The brand enjoys recognition due to its affordable pricing and lack of queues. To preserve cash, management has eschewed costly franchise buybacks, focusing instead on the organic growth of the clinic count.

The Joint - JYNT Price to Earnings Ratio (period 07/04/2022 - 11/12/2026)

Comprehensive metric breakdowns and analytics for The Joint Corporation (JYNT)

- stock value and consensus price forecast:
- market capitalization indicators:
Summary company analysis:JYNT (thejoint.com)
Finished products of The Joint

The ratio is calculated as market capitalization divided by net income, determining the cost of one dollar of annual earnings. This metric measures the actual payback period of the investment, filtering out market noise from real returns. For the scalable franchise of The Joint Corp. (JYNT) with a fixed ticket price, this calculation confirms the efficiency of mass demand. By analyzing the P/E based on the company's financial statements, an investor can rebalance their portfolio in a timely manner.

Competing companies

Price to Earnings Ratio HCA Holdings (HCA)|P/E Multiple THC|FMS - Market Cap to Earnings|Price to Earnings Ratio Solventum Inc. SOLV|EHC: Price to Earnings Multiple|UHS: Price to Earnings Ratio|davita.com - Market Price to Net Income Ratio|RDNT (RadNet) - Price to Earnings Ratio|OPCH: Market Price to Net Income Ratio|SGRY (Surgery Partners Corp) - P/E Multiple|PINC: Company Value to Net Income|P/E Multiple EYE|PGNY - Market Cap to Earnings|Ardent Health Partners - Price to Earnings Ratio|Company Value to Net Income SEM|ASTH - Price to Earnings Ratio|Pediatrix Medical - Market Price to Net Income Ratio|usph.com (USPH) - Price to Earnings Ratio|Market Cap to Earnings pennantgroup.com (PNTG)|ORGO (Organogenesis) - P/E Multiple|Nutex Health Inc (NUTX) - Business Payback Period|Price to Earnings Ratio Auna Health (AUNA)|SBC Medical Group Inc - Price to Earnings Multiple|Evolus, Inc. - Price to Earnings Ratio|Market Price to Net Income Ratio CYH (chs.net)|SKIN: Price to Earnings Ratio|Company Value to Net Income MDWD (MediWound Ltd.)|BTMD: P/E Multiple|Price to Earnings Ratio DocGo, Inc|Price to Earnings Ratio P3 Health Partners, Inc.|Market Cap to Earnings gaintherapeutics.com GANX|Price to Earnings Ratio EUDA Health Holdings Limited (EUDA)|BMGL (baselmedical.com) - Company Value to Net Income|Price to Earnings Ratio CollPlant Biotechnologies Ltd. CLGN|CUPR (Cuprina Holdings Limited) - Market Cap to Net Income|CCM: Price to Earnings Ratio|Business Payback Period ashs.com AMS|MEDIROM Healthcare Group (MRM) - Price to Earnings Ratio|ALBT: Market Price to Net Income Ratio|Price to Earnings Ratio DHAI|Market Cap to Earnings Carmell Corp XAGE|Price to Earnings Ratio NewGenIvf Group Limited (NIVF)|atipt.com - Price to Earnings Multiple|CareMax - Price to Earnings Ratio|Market Price to Net Income Ratio KDLY (Kindly MD Inc)|MODV: Price to Earnings Ratio|Novo Integrated Sciences Corp - Market Price to Net Income Ratio|sunlinkhealth.com (SSY) - Price to Earnings Ratio|imacholdings.comm - Company Value to Net Income